Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 24.9% | 8.4% | 13.4% | 33.7% | -69.5% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.9 |
| Gross margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Selling, general and administrative | 8.1 | 9.2 | 8.2 | 11.7 | 11.8 | 9.9 | 5.5 | 1.9 |
| Research and development | 9.1 | 8.8 | 8.7 | 11.8 | 23.3 | 17.3 | 5.8 | |
| EBITA | -17.2 | -18.0 | -17.0 | -23.5 | -35.1 | -27.2 | -11.3 | -2.0 |
| EBITA margin | 62637.9% | 81705.7% | 83537.5% | 131100.3% | 261939.6% | 61967.7% | 25554.7% | |
| Amortization of intangibles | | | | | | | 19.3 | |
| EBIT | -17.2 | -18.0 | -17.0 | -23.5 | -35.1 | -27.2 | -30.6 | -2.0 |
| EBIT margin | 62637.9% | 81705.7% | 83537.5% | 131100.3% | 261939.6% | 61967.7% | 69158.3% | |
| Pre-tax income | -17.4 | -17.1 | -16.8 | -20.5 | -35.4 | -18.1 | -45.3 | -1.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -17.4 | -17.1 | -16.8 | -20.5 | -35.4 | -18.1 | -45.3 | 0.0 |
| Net margin | 63402.4% | 77619.0% | 82961.7% | 114432.6% | 264291.9% | 41258.6% | 102472.7% | |
| |
| Diluted EPS | $0.00 | ($0.01) | ($0.01) | ($0.01) | ($0.03) | ($0.02) | ($0.05) | $0.00 |
| Shares outstanding (diluted) | 4,292.1 | 3,159.0 | 1,831.0 | 1,540.3 | 1,247.3 | 1,177.7 | 852.1 | 85.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|